Used as a key chiral intermediate in the synthesis of biologically active pharmaceuticals, particularly in the development of kinase inhibitors. Its structural motif is valuable in medicinal chemistry for targeting enzymes involved in inflammatory and oncological pathways. The fluoropyridine group enhances binding affinity and metabolic stability, making it suitable for oral drugs. Commonly employed in asymmetric synthesis to introduce chirality in drug candidates, improving selectivity and reducing off-target effects.